These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 29454156)

  • 21. Structure-guided design of new indoles as negative allosteric modulators (NAMs) of N-methyl-D-aspartate receptor (NMDAR) containing GluN2B subunit.
    Buemi MR; De Luca L; Ferro S; Russo E; De Sarro G; Gitto R
    Bioorg Med Chem; 2016 Apr; 24(7):1513-9. PubMed ID: 26912202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and characterization of novel NMDA receptor antagonists selective for NR2A- over NR2B-containing receptors.
    Bettini E; Sava A; Griffante C; Carignani C; Buson A; Capelli AM; Negri M; Andreetta F; Senar-Sancho SA; Guiral L; Cardullo F
    J Pharmacol Exp Ther; 2010 Dec; 335(3):636-44. PubMed ID: 20810618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Temperature dependence of N-methyl-D-aspartate receptor channels and N-methyl-D-aspartate receptor excitatory postsynaptic currents.
    Korinek M; Sedlacek M; Cais O; Dittert I; Vyklicky L
    Neuroscience; 2010 Feb; 165(3):736-48. PubMed ID: 19883737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Structure-Activity Relationship of a Tetrahydroisoquinoline Class of N-Methyl-d-Aspartate Receptor Modulators that Potentiates GluN2B-Containing N-Methyl-d-Aspartate Receptors.
    Strong KL; Epplin MP; Bacsa J; Butch CJ; Burger PB; Menaldino DS; Traynelis SF; Liotta DC
    J Med Chem; 2017 Jul; 60(13):5556-5585. PubMed ID: 28586221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human induced pluripotent stem cell (hiPSC)-derived neurons respond to convulsant drugs when co-cultured with hiPSC-derived astrocytes.
    Ishii MN; Yamamoto K; Shoji M; Asami A; Kawamata Y
    Toxicology; 2017 Aug; 389():130-138. PubMed ID: 28666936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GluN2B-containing NMDA receptors as possible targets for the neuroprotective and antidepressant effects of fluoxetine.
    Kiss JP; Szasz BK; Fodor L; Mike A; Lenkey N; Kurkó D; Nagy J; Vizi ES
    Neurochem Int; 2012 Jan; 60(2):170-6. PubMed ID: 22197911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Developmental Changes of Synaptic and Extrasynaptic NMDA Receptor Expression in Rat Cerebellar Neurons In Vitro.
    Sibarov DA; Stepanenko YD; Silantiev IV; Abushik PA; Karelina TV; Antonov SM
    J Mol Neurosci; 2018 Feb; 64(2):300-311. PubMed ID: 29285738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Depletion of Progranulin Reduces GluN2B-Containing NMDA Receptor Density, Tau Phosphorylation, and Dendritic Arborization in Mouse Primary Cortical Neurons.
    Longhena F; Zaltieri M; Grigoletto J; Faustini G; La Via L; Ghidoni R; Benussi L; Missale C; Spano P; Bellucci A
    J Pharmacol Exp Ther; 2017 Nov; 363(2):164-175. PubMed ID: 28899992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endocytosis of GluN2B-containing NMDA receptors mediates NMDA-induced excitotoxicity.
    Wu Y; Chen C; Yang Q; Jiao M; Qiu S
    Mol Pain; 2017 Jan; 13():1744806917701921. PubMed ID: 28326942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthetic conantokin peptides potently inhibit N-methyl-D-aspartate receptor-mediated currents of retinal ganglion cells.
    Huang L; Balsara RD; Castellino FJ
    J Neurosci Res; 2014 Dec; 92(12):1767-74. PubMed ID: 25043917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Homocysteine reduces NMDAR desensitization and differentially modulates peak amplitude of NMDAR currents, depending on GluN2 subunit composition.
    Bolton AD; Phillips MA; Constantine-Paton M
    J Neurophysiol; 2013 Oct; 110(7):1567-82. PubMed ID: 23864370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of nonsynaptic GluN2B-containing NMDA receptors in excitotoxicity: evidence that fluoxetine selectively inhibits these receptors and may have neuroprotective effects.
    Vizi ES; Kisfali M; Lőrincz T
    Brain Res Bull; 2013 Apr; 93():32-8. PubMed ID: 23089362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NMDA and AMPA receptor expression and cortical neuronal death are associated with p38 in glutamate-induced excitotoxicity in vivo.
    Rivera-Cervantes MC; Torres JS; Feria-Velasco A; Armendariz-Borunda J; Beas-Zárate C
    J Neurosci Res; 2004 Jun; 76(5):678-87. PubMed ID: 15139026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Minimized cell usage for stem cell-derived and primary cells on an automated patch clamp system.
    Becker N; Stoelzle S; Göpel S; Guinot D; Mumm P; Haarmann C; Malan D; Bohlen H; Kossolov E; Kettenhofen R; George M; Fertig N; Brüggemann A
    J Pharmacol Toxicol Methods; 2013; 68(1):82-7. PubMed ID: 23567076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The glutamate receptor GluN2 subunit regulates synaptic trafficking of AMPA receptors in the neonatal mouse brain.
    Hamada S; Ogawa I; Yamasaki M; Kiyama Y; Kassai H; Watabe AM; Nakao K; Aiba A; Watanabe M; Manabe T
    Eur J Neurosci; 2014 Oct; 40(8):3136-46. PubMed ID: 25131300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of Plasma Membrane Na/Ca-Exchanger by KB-R7943 or Lithium Reveals Its Role in Ca-Dependent N-methyl-d-aspartate Receptor Inactivation.
    Sibarov DA; Abushik PA; Poguzhelskaya EE; Bolshakov KV; Antonov SM
    J Pharmacol Exp Ther; 2015 Dec; 355(3):484-95. PubMed ID: 26391160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New advances in NMDA receptor pharmacology.
    Ogden KK; Traynelis SF
    Trends Pharmacol Sci; 2011 Dec; 32(12):726-33. PubMed ID: 21996280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular basis of positive allosteric modulation of GluN2B NMDA receptors by polyamines.
    Mony L; Zhu S; Carvalho S; Paoletti P
    EMBO J; 2011 Jun; 30(15):3134-46. PubMed ID: 21685875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Piroxicam inhibits NMDA receptor-mediated excitotoxicity through allosteric inhibition of the GluN2B subunit: an in silico study elucidating a novel mechanism of action of the drug.
    Mazumder MK; Borah A
    Med Hypotheses; 2014 Dec; 83(6):740-6. PubMed ID: 25459147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aβ and NMDAR activation cause mitochondrial dysfunction involving ER calcium release.
    Ferreira IL; Ferreiro E; Schmidt J; Cardoso JM; Pereira CM; Carvalho AL; Oliveira CR; Rego AC
    Neurobiol Aging; 2015 Feb; 36(2):680-92. PubMed ID: 25442114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.